English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 9, 2026

GLP-1 medications show potential heart health benefits beyond weight loss
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

FDA resumes rare pediatric voucher program; launches new initiatives for pharma regulation
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Penn Medicine researchers use cryoEM technology for breakthroughs in cell division and protein structure
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Penn Medicine researchers advance disease study with cutting-edge cryogenic electron microscopy
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Penn Medicine scientists use advanced imaging tools for flu and cancer drug discovery
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Study finds hundreds of potential food allergy risks but rules out vaccine connection
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies
+ Pharmaceuticals
Patient Daily | Feb 9, 2026

Penn Medicine researchers use advanced imaging tools to reveal disease mechanisms

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones